Eli Lilly Rips Expert For 'Unreliable' Cymbalta Testimony

Law360, New York (May 1, 2015, 6:49 PM EDT) -- Eli Lilly & Co. has argued that a causation expert for the plaintiffs in two lawsuits over its anti-depressant Cymbalta offered "unreliable" testimony at a recent deposition on issues including medical diagnosis for one of the plaintiffs and certain internal company documents. 

In a filing in California federal court, Eli Lilly sought to exclude the testimony of Dr. Joseph Glenmullen, arguing that he lacked the expertise to testify on plaintiff Claudia Herrera's diagnoses for the hormone-related conditions hypothyroidism and perimenopause. The suits by Herrera and plaintiff Nikki...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Claudia Herrera et al v. Eli Lilly and Company et al


Case Number

2:13-cv-02702

Court

California Central

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Stephen V. Wilson

Date Filed

April 17, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.